title: Sublobar Resection: Ongoing Controversy for Treatment for Stage I Non-Small Cell Lung Cancer.
abstract: Despite a prospective randomized trial that reported decreased locoregional recurrence for the intentional use of sublobar resection for stage IA non-small cell lung cancer, it continues to be a point of considerable debate. Improved imaging techniques have introduced a large group of smaller and more indolent tumors than what was studied 20 years ago by the Lung Cancer Study Group. Multiple single-institution and population-based analyses suggest that sublobar resections may have equivalent outcomes to lobectomy in well-selected patients with small (<2 cm) resections, and in whom an adequate resection margin can be achieved.
authors.affiliation: Department of Cardiothoracic Surgery, NYU School of Medicine, 530 1st Avenue, Suite 9V, New York, NY 10016, USA.
authors.forename: Joanna
authors.initials: J
authors.lastname: Sesti
authors.affiliation: Department of Cardiothoracic Surgery, NYU School of Medicine, 530 1st Avenue, Suite 9V, New York, NY 10016, USA. Electronic address: jessica.donington@nyumc.org.
authors.forename: Jessica S
authors.initials: JS
authors.lastname: Donington
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000601:surgery*; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000601:surgery*; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000379:methods*
keywords: Adenocarcinoma in situ; Minimally invasive adenocarcinoma; Non–small cell lung cancer; Sublobar resection